NASDAQ: CHRNChronoscale Holdings Corp Stock
$12.05-1.63 (-11.92%)
Updated Nov 4, 2026
Shares of IT services companies... find out Why CHRN Price Moved with a free WallStreetZen account
Why Price MovedCHRN Price
$12.05
Fair Value Price
N/A
Market Cap
$1.75B
52 Week Low
$3.50
52 Week High
$30.00
P/E
N/A
P/B
11.65x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.96
Operating Cash Flow
N/A
Beta
0.97
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CHRN Overview
ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas. ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CHRN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Information Technology Service
Industry Rating
D
CHRN
Ranked#21 of 56
Ranked#21 of 56
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $26.12 | A | |
| $150.45 | A | |
| $43.12 | B |
Be the first to know about important CHRN news, forecast changes, insider trades & much more!
CHRN News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CHRN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CHRN is poor value based on its book value relative to its share price (11.65x), compared to the US Information Technology Services industry average (4x)
P/B vs Industry Valuation
CHRN's short-term liabilities ($101.17M) exceed its short-term assets ($30.69M)
Short-term Liabilities Financials
CHRN's long-term liabilities ($43.58M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more CHRN due diligence checks available for Premium users.
Valuation
CHRN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0x
Industry
15.8x
Market
43.64x
CHRN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
11.65x
Industry
4x
CHRN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CHRN's financial health
Profit margin
Revenue
$41.5M
Net Income
-$42.5M
Profit Margin
-102.4%
Assets to liabilities
Assets
$295.4M
Liabilities
$144.8M
Debt to equity
0.96
CHRN's short-term liabilities ($101.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CHRN's long-term liabilities ($43.58M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CHRN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CHRN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$14.6M
Investing
-$3.1M
Financing
-$6.0M
CHRN vs Information Technology Service Stocks
Chronoscale Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.